BSIP2024_Flyer
BC-Seminar-2024050_RT
BC Faculty Seminar: January 4, 2024
BC Faculty Seminar “The versatility of MarR domain in the regulation of phenolic compound utilization” by Assoc. Prof. Danaya Pakotiprapha ...
BC Special Seminar: January 24, 2024
"Application of highly immunodeficient mice for cancer research and drug development" by Professor Seiji Okada, MD, PhD "Establishment and application ...
BC Special Seminar: January 15, 2024
BC Special Seminar “Science Careers in Pharma Beyond the Bench” by Chatarin (Chad) Wangsanuwat, Ph.D. University of California, Santa Barbara ...
BC Special Seminar: January 24, 2024
BC Special Seminar “Science Careers in Pharma Beyond the Bench” by Dr. Oleg Lavrukhin Regional Field Medical Lead Sanofi US ...
Research Highlights
Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation
Cholangiocarcinoma (CCA) is a difficult-to-treat cancer, with limited therapeutic options and surgery being the only curative treatment. Standard chemotherapy involves ...
Targeting MYC at the intersection between cancer metabolism and oncoimmunology
MYC activation is a known hallmark of cancer as it governs the gene targets involved in various facets of cancer ...